| pubmed-article:3913231 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:3913231 | lifeskim:mentions | umls-concept:C0017626 | lld:lifeskim |
| pubmed-article:3913231 | lifeskim:mentions | umls-concept:C0750974 | lld:lifeskim |
| pubmed-article:3913231 | lifeskim:mentions | umls-concept:C0027627 | lld:lifeskim |
| pubmed-article:3913231 | lifeskim:mentions | umls-concept:C0021044 | lld:lifeskim |
| pubmed-article:3913231 | lifeskim:mentions | umls-concept:C0237881 | lld:lifeskim |
| pubmed-article:3913231 | lifeskim:mentions | umls-concept:C0750502 | lld:lifeskim |
| pubmed-article:3913231 | pubmed:issue | 5 | lld:pubmed |
| pubmed-article:3913231 | pubmed:dateCreated | 1986-3-31 | lld:pubmed |
| pubmed-article:3913231 | pubmed:abstractText | 8 cases were studied to determine whether immunohistochemical investigation with anti-GFAP could contribute to confirming a primary brain tumor origin for an extracranial metastasis. The materials studied consisted of 3 glioblastomas, 3 anaplastic astrocytomas, and 2 medulloblastomas, along with their extracranial metastases. GFAP could be immunohistochemically demonstrated in all 6 primary glial tumors as well as in the metastases of the 3 astrocytomas and of 2 glioblastomas. The medulloblastomas and their metastases were immunohistochemically GFAP-negative. GFAP is thus a marker for extracranial metastases of astrocytomas and glioblastomas. A negative result however does not exclude the possibility that a metastasis is of glial origin as shown by the GFAP-negative metastasis of the one glioblastoma. | lld:pubmed |
| pubmed-article:3913231 | pubmed:language | ger | lld:pubmed |
| pubmed-article:3913231 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:3913231 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:3913231 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:3913231 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:3913231 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:3913231 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:3913231 | pubmed:issn | 0044-4030 | lld:pubmed |
| pubmed-article:3913231 | pubmed:author | pubmed-author:MartinHH | lld:pubmed |
| pubmed-article:3913231 | pubmed:author | pubmed-author:JandaJJ | lld:pubmed |
| pubmed-article:3913231 | pubmed:author | pubmed-author:BassPP | lld:pubmed |
| pubmed-article:3913231 | pubmed:author | pubmed-author:GottschalkJJ | lld:pubmed |
| pubmed-article:3913231 | pubmed:author | pubmed-author:KretschmerBB | lld:pubmed |
| pubmed-article:3913231 | pubmed:author | pubmed-author:SzymasJJ | lld:pubmed |
| pubmed-article:3913231 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:3913231 | pubmed:volume | 130 | lld:pubmed |
| pubmed-article:3913231 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:3913231 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:3913231 | pubmed:pagination | 391-6 | lld:pubmed |
| pubmed-article:3913231 | pubmed:dateRevised | 2006-11-15 | lld:pubmed |
| pubmed-article:3913231 | pubmed:meshHeading | pubmed-meshheading:3913231-... | lld:pubmed |
| pubmed-article:3913231 | pubmed:meshHeading | pubmed-meshheading:3913231-... | lld:pubmed |
| pubmed-article:3913231 | pubmed:meshHeading | pubmed-meshheading:3913231-... | lld:pubmed |
| pubmed-article:3913231 | pubmed:meshHeading | pubmed-meshheading:3913231-... | lld:pubmed |
| pubmed-article:3913231 | pubmed:meshHeading | pubmed-meshheading:3913231-... | lld:pubmed |
| pubmed-article:3913231 | pubmed:meshHeading | pubmed-meshheading:3913231-... | lld:pubmed |
| pubmed-article:3913231 | pubmed:meshHeading | pubmed-meshheading:3913231-... | lld:pubmed |
| pubmed-article:3913231 | pubmed:meshHeading | pubmed-meshheading:3913231-... | lld:pubmed |
| pubmed-article:3913231 | pubmed:meshHeading | pubmed-meshheading:3913231-... | lld:pubmed |
| pubmed-article:3913231 | pubmed:meshHeading | pubmed-meshheading:3913231-... | lld:pubmed |
| pubmed-article:3913231 | pubmed:meshHeading | pubmed-meshheading:3913231-... | lld:pubmed |
| pubmed-article:3913231 | pubmed:meshHeading | pubmed-meshheading:3913231-... | lld:pubmed |
| pubmed-article:3913231 | pubmed:meshHeading | pubmed-meshheading:3913231-... | lld:pubmed |
| pubmed-article:3913231 | pubmed:meshHeading | pubmed-meshheading:3913231-... | lld:pubmed |
| pubmed-article:3913231 | pubmed:meshHeading | pubmed-meshheading:3913231-... | lld:pubmed |
| pubmed-article:3913231 | pubmed:meshHeading | pubmed-meshheading:3913231-... | lld:pubmed |
| pubmed-article:3913231 | pubmed:meshHeading | pubmed-meshheading:3913231-... | lld:pubmed |
| pubmed-article:3913231 | pubmed:year | 1985 | lld:pubmed |
| pubmed-article:3913231 | pubmed:articleTitle | [Significance of immunohistochemistry in neuro-oncology. I. Demonstration of glial fibrillary acid protein (GFAP) in extracranial metastases from primary brain tumors]. | lld:pubmed |
| pubmed-article:3913231 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:3913231 | pubmed:publicationType | English Abstract | lld:pubmed |
